𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Childhood acute lymphoblastic Leukemia: Differences in drug resistance between sub-groups of ALL

✍ Scribed by A. J. P. Veerman

Publisher
Carden Jennings Publishing
Year
2002
Tongue
English
Weight
423 KB
Volume
76
Category
Article
ISSN
0925-5710

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical relevance of in vitro drug resi
Clinical relevance of in vitro drug resistance testing in childhood acute lymphoblastic leukemia: The state of the art
✍ Pieters, Rob ;Kaspers, Gertjan J. L. ;Klumper, Edwin ;Veerman, Anjo J.P. πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 891 KB

## Abstract Nowadays about two‐thirds of children with acute lymphoblastic leukemia (ALL) can be cured with chemotherapy, but one‐third die from the disease. The clinical response of leukemic cells to chemotherapy is roughly due to two factors: the effective drug levels reaching the cells and the r

Childhood acute lymphoblastic leukemia:
Childhood acute lymphoblastic leukemia: Results of the austrian cooperative study group with the all a 84 protocol
✍ Gruemayer, Eva Renate ;Gadner, Helmut ;Mutz, Ingomar ;Urban, Christian ;Ausserer πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 764 KB

## Abstract We prospectively treated 127 children with ALL with a risk‐adapted regimen. All patients received the identical induction‐consolidation therapy. The early maintenance included intermediate dose methotrexate in patients with standard risk (n = 79) and medium risk (n = 39). In addition pa